| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 09/08/2004 | EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/08/2004 | EP1453514A1 Piperazine derivatives for use as ccr-3 receptor antagonists in the treatment of asthma |
| 09/08/2004 | EP1453501A1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
| 09/08/2004 | EP1165505B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 09/08/2004 | CN1526700A Synthesis of Important intermediate for mosapride citrate |
| 09/07/2004 | US6787544 Useful for prophylaxis and therapy of virus infections and especially influenza virus infections |
| 09/07/2004 | US6787543 Preparation of tachykinin antagonists; substituted nitrogen-containing heterocycles |
| 09/02/2004 | WO2004073634A2 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 09/02/2004 | WO2004073629A2 Hetero substitued sodium channel blockers |
| 09/02/2004 | WO2004073619A2 Ccr8 antagonists |
| 09/02/2004 | US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/02/2004 | US20040171655 Active against cancer proliferation, growth, and metastasis; such as 3,4,5-trimethoxy-n-(2-methyl-3-phenyl-allyl)-n-[2-(1-methyl-pyrrolidin-2-yl)-thyl]-benzamide; side effect reduction |
| 09/02/2004 | US20040171654 Sulfur compounds such as 4-tert-Butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzenesulfonamide, used as chemokine receptor antagonists, antiinflamatory agents or as immunology modulators |
| 09/02/2004 | US20040171642 Neurokinin 1 (NK-1) receptor antagonists; depression, anxiety, pain, inflammation, migraine, emesis, postherpetic neuralgia |
| 09/02/2004 | US20040171641 Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP) |
| 09/02/2004 | US20040171618 Compounds as PDE IV and TNF-inhibitors |
| 09/02/2004 | US20040171603 Novel therapeutic targets for the treatment of mycobacterial infections and compounds useful therefor |
| 09/02/2004 | US20040171520 Melanocortin receptor-specific peptidomimetics |
| 09/02/2004 | US20040170863 Organic electroluminescent devices using double-spiro organic compounds |
| 09/02/2004 | US20040170634 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 09/02/2004 | CA2767153A1 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 09/01/2004 | EP1451159A1 Compositions derived from quinoline and quinoxaline, preparation and use thereof |
| 09/01/2004 | EP1451158A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties |
| 09/01/2004 | EP1451157A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties |
| 09/01/2004 | EP1048655B1 1,2-dihydro-2-oxoquinoline derivatives |
| 09/01/2004 | CN1525975A Tert. alkylphenoxy substituted polycyclic compounds |
| 09/01/2004 | CN1525957A Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 09/01/2004 | CN1164578C Fluidized bed catalyst for preparing 2-cyano pyrazine |
| 09/01/2004 | CN1164334C Sustained release formulation of peptide |
| 08/26/2004 | WO2004072087A2 Metal complexes as light-absorbing compounds in the information layer of optical data carriers |
| 08/26/2004 | WO2004071390A2 Piperazine-2-carboxamide derivatives |
| 08/26/2004 | US20040167332 Boronic ester and acid compounds, synthesis and uses |
| 08/26/2004 | US20040167201 Pyrrolidine melanocortin-specific compounds |
| 08/26/2004 | US20040167198 Vasculostatic agents and methods of use thereof |
| 08/26/2004 | US20040167182 Hydroxamic acid and amide compounds and their use as protease inhibitors |
| 08/26/2004 | US20040167126 Such as (2RS,3R)-3-amino-4-cyclohexyl-2-hydroxy-N-phenoxybutanamide; methionine aminopeptidase type 2 inhibitors |
| 08/26/2004 | US20040167113 Bis-aryl sulfonamides |
| 08/26/2004 | CA2513716A1 Piperazine-2-carboxamide derivatives |
| 08/25/2004 | EP1449834A2 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas |
| 08/25/2004 | EP1448535A1 Benzamide and heteroarylamide as p2x7 receptor antagonists |
| 08/25/2004 | EP1448534A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition ofthe coagulation cascade |
| 08/25/2004 | EP1448514A1 Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives |
| 08/25/2004 | EP1448180A1 Para-amino benzoic acids as integrin antagonists |
| 08/25/2004 | CN1522701A Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy |
| 08/25/2004 | CN1163490C Method for preparing cyclic thioamide compound |
| 08/24/2004 | US6780992 Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
| 08/19/2004 | WO2004069813A1 Saturated quinoxaline derivatives and their use as metabotropic glutamate receptor ligands |
| 08/19/2004 | WO2004058755A3 Compound libraries of imidazo[1,5-a]pyridin-3-yl derivatives and related heterobicycles for targetting compounds capable of binding to g-protein coupled receptors |
| 08/19/2004 | WO2004058720A3 Compound libraries of 1,3,5-substitute indazole derivatives as compounds for targetting compounds capable of binding to the g-protein coupled receptor |
| 08/19/2004 | WO2004058705A3 Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor |
| 08/19/2004 | WO2003094853A3 Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists |
| 08/19/2004 | WO2003049702A8 Vanilloid receptor ligands and their use in treatments |
| 08/19/2004 | US20040162321 For therapy of disease characterized by inflammatory, allergic, or proliferative processes |
| 08/19/2004 | US20040162296 Nitrogen compounds such as 4-(4-(N-(3,5-diamino-6-chloro-pyrazine-2-carbonyl)guanidino)butyl)-N-(2 -aminoethyl)benzamide hydrochloride, administered for prophylaxis of respiratory system disorders; pharmocokinetics |
| 08/19/2004 | CA2513824A1 Saturated quinoxaline derivatives and their use as metabotropic glutamate receptor ligands |
| 08/18/2004 | EP1447401A1 Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient |
| 08/18/2004 | EP1447398A1 Retroviral protease inhibitors |
| 08/18/2004 | EP1446387A1 Substituted aryl 1,4-pyrazine derivatives |
| 08/18/2004 | EP1446224A2 Aromatic compounds containing nitrogen and p-functionalized amines, the production thereof and their use in catalytic reactions |
| 08/18/2004 | EP0876345B1 Heterocyclic compounds as h+-atpases |
| 08/18/2004 | CN1522245A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes |
| 08/17/2004 | US6777446 Farnesoid x receptor; treating diseases associated with abnormally high or low cholesterol levels. |
| 08/17/2004 | US6777431 Non-convalent thrombin inhibitors |
| 08/17/2004 | US6777413 For therapy and prophylaxis of conditions in mammals characterized by undesired thrombosis |
| 08/12/2004 | WO2004067675A2 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes |
| 08/12/2004 | WO2004067498A2 Aryl alkyl carbamate derivatives production and use thereof in therapy |
| 08/12/2004 | WO2004030635A3 Vasculostatic agents and methods of use thereof |
| 08/12/2004 | US20040158076 Tyrosine derivatives |
| 08/12/2004 | US20040157860 Pyrazine compounds as CRF modulators |
| 08/12/2004 | US20040157858 Piperazine derivatives as tachykinin antagonists |
| 08/12/2004 | US20040157264 Piperazine melanocortin-specific compounds |
| 08/12/2004 | CA2511941A1 Aryl alkyl carbamate derivatives production and use thereof in therapy |
| 08/11/2004 | EP1444545A2 Controlled diffusion coefficient electrochromic materials for use in electrochromic mediums and associated electrochromic devices |
| 08/11/2004 | EP1444212A1 Substituted (1h)-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds |
| 08/11/2004 | EP1444197A1 Novel phenyl-propargylether derivatives |
| 08/11/2004 | EP1444196A1 Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives |
| 08/11/2004 | EP1027713A4 Nonaqueous electrolyte for electrical storage devices |
| 08/11/2004 | CN1520409A Piperazine oxime derivatives having Nk-1 receptor antagonistic activity |
| 08/11/2004 | CN1520404A Piperazinylpyrazines compounds as antagonists of serotonin-5-HT2 receptor |
| 08/11/2004 | CN1519240A Substituted nitrogen contg. heterocycles as inhibitors of P38 progein kinase |
| 08/11/2004 | CN1519230A Process of preparing cyclic thioacid amide compound |
| 08/11/2004 | CN1161344C 6,7-asmmetrically disubstituted quinoxalinecarboxylic acid derivatives, addition salts thereof and process for preparation of both |
| 08/10/2004 | US6774138 To function as agonists or antagonists of receptors for neurotransmitters, neurohormones and neuromodulators, as insecticides and fingicides |
| 08/10/2004 | CA2134566C 1-piperazino-1,2-dihydroindene derivatives |
| 08/05/2004 | WO2004065369A1 Carboxamide derivatives and their use as factor xa inhibitors |
| 08/05/2004 | WO2004064972A2 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 08/05/2004 | US20040152745 Dipeptidyl peptidase IV inhibitors and methods of making and using dipeptidyl peptidase IV inhibitors |
| 08/05/2004 | US20040152704 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 08/05/2004 | US20040152703 Controlling fertility; contraceptiives |
| 08/05/2004 | US20040152134 Eating disorders; sexual disorders; erectile dysfunction |
| 08/05/2004 | US20040152133 Oligomers and polymers of di-substituted cyclic imino carboxylic acids |
| 08/05/2004 | US20040151945 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes |
| 08/05/2004 | CA2514100A1 Carboxamide derivatives and the use thereof as factor xa inhibitors |
| 08/04/2004 | EP1442011A1 Zwitterionic imides |
| 08/04/2004 | EP1189875B1 Mono and multifunctional alkoxyamines for the preparation of functionalized macromers |
| 08/04/2004 | EP0912571B1 Naphthyridines which affect il-4 and g-csf |
| 08/04/2004 | CN1518544A Piperazine derivative, process for producing the same, polymeric solid electrolyte and secondary battery |
| 08/04/2004 | CN1518541A Phenyl derivatives |
| 08/03/2004 | US6770771 Catalyst systems of alpha -diimine, urethane or urea ligands complexed to nickel, palladium or other transition metals |
| 08/03/2004 | US6770667 N-((imidazolyl)-phenyl)-fluorene-1-carboxamide derivatives; 5-hydroxytryptamine (5-ht) antagonists; psychological, nervous system, eating, brain and sleep disorders |